CLINICAL ROLE -
Novel Immunotherapies in Perioperative Setting in Muscle-Invasive Bladder Cancer May Transform Clinical Practice
Systemic treatment options have historically been limited to traditional chemotherapy agents.
Read More
Neoadjuvant, Adjuvant Therapy for Resectable NSCLC Progresses With Immunotherapy, Targeted Therapy
Significant advancements have changed the treatment landscape and clinical practice procedures.
Immunotherapy Makes Major Strides for First-line Treatment of Unresectable Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma
Specific immune checkpoint inhibitors added to frontline chemotherapy have transformed modern clinical practice.